HAHaydee Artaza

Haydee Artaza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Haydee Artaza has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Contribution of Rare Large High-Penetrance CNVs to Pediatric and MODY Diabetes in Norway

    by Haydee Artaza, Divya Sri Priyanka Tallapragada, Janne Molnes, Ksenia Lavrichenko, Anette S.B. Wolff, Ellen C. Røyrvik, Torild Skrivarhaug, Marc Vaudel, Eirik Bratland, Bente B. Johansson, et al.

    Technological advancements have significantly improved our understanding of Copy Number Variants (CNVs) and their role in disease. However, detecting CNVs in clinical diagnostics remains challenging, and important pathogenic CNVs may go undetected. This study systematically assessed the impact of rare, large, high-penetrance CNVs on pediatric diabetes and Maturity-onset Diabetes of the Young (MODY) in Norway. We analyzed data from the nationwide Norwegian Childhood Diabetes Registry (NCDR) covering 2002-2018 and the Norwegian MODY Registry (NMR) from 1997-2019. CNV detection was performed using the Illumina Infinium Global Screen Array-24 v2.0 on a total of 5,889 individuals and we compared the results to diagnostic records. Our findings indicate that 0.63% of the patients in the Norwegian MODY Registry and 0.09% in the Norwegian Childhood Diabetes Registry are attributable to established pathogenic large copy number deletions detectable by array genotyping. Notably, six of the 14 pathogenic deletions identified (in the HNF1B [n=3], HNF1A [n=2], or GATA4 genes [n=1]) had not been detected through standard diagnostic methods in the routine diagnostic screening. For these individuals, accurate molecular diagnoses have significant implications for personalized treatment and follow-up. We found no evidence suggesting a major role for additional rare CNVs beyond the already established pathogenic CNVs in MODY. In conclusion, while pathogenic CNVs are rare, they remain relevant for patients of the Norwegian nationwide diabetes registries. Expanding screening for MODY variants, specifically 17q12-HNF1B and HNF1A deletions, to a larger portion of the pediatric diabetes population should be considered.


  • Open Access

    Rare Copy Number Variant analysis in case-control studies using SNP Array Data: a scalable and automated data analysis pipeline

    by Haydee Artaza, Ksenia Lavrichenko, Anette S.B. Wolff, Ellen C. Røyrvik, Marc Vaudel, Stefan Johansson

    Background: Rare copy number variants (CNVs) significantly influence the human genome and may contribute to disease susceptibility. High-throughput SNP genotyping platforms provide data that can be used for CNV detection, but it requires the complex pipelining of bioinformatic tools. Here, we propose a flexible bioinformatic pipeline for rare CNV analysis from human SNP array data. Results: The pipeline performs two major tasks: (1) CNV detection and quality control, and (2) rare CNV analysis. It is implemented in Snakemake following a rule-based structure that enables automation and scalability while maintaining flexibility. Conclusions: Our pipeline automates the detection and analysis of rare CNVs. It implements a rigorous CNV quality control, assesses the frequencies of these rare CNVs in patients versus controls, and evaluates the impact of CNVs on specific genes or pathways. We hence aim to provide an efficient yet flexible bioinformatic framework to investigate rare CNVs in biomedical research.


  • Open Access

    GWAS for autoimmune Addison’s disease identifies multiple risk loci and highlights AIRE in disease susceptibility

    by Daniel Eriksson, Ellen Christine Røyrvik, Maribel Aranda-Guillén, Amund Holte Berger, Nils Landegren, Haydee Artaza, Åsa Hallgren, Marianne Aardal Grytaas, Sara Ström, Eirik Bratland, et al.

    Autoimmune Addison’s disease (AAD) is characterized by the autoimmune destruction of the adrenal cortex. Low prevalence and complex inheritance have long hindered successful genetic studies. We here report the first genome-wide association study on AAD, which identifies nine independent risk loci (P < 5 × 10−8). In addition to loci implicated in lymphocyte function and development shared with other autoimmune diseases such as HLA, BACH2, PTPN22 and CTLA4, we associate two protein-coding alterations in Autoimmune Regulator (AIRE) with AAD. The strongest, p.R471C (rs74203920, OR = 3.4 (2.7–4.3), P = 9.0 × 10−25) introduces an additional cysteine residue in the zinc-finger motif of the second PHD domain of the AIRE protein. This unbiased elucidation of the genetic contribution to development of AAD points to the importance of central immunological tolerance, and explains 35–41% of heritability (h2).


  • Open Access

    Identification and characterization of rare toll-like receptor 3 variants in patients with autoimmune Addison's disease

    by Sigrid Aslaksen, Anette B. Wolff, Magnus D. Vigeland, Lars Breivik, Ying Sheng, Bergithe E. Oftedal, Haydee Artaza, Beate Skinningsrud, Dag E. Undlien, Kaja K. Selmer, et al.


  • Silenced retrotransposons are major rasiRNAs targets in Arabidopsis galls induced by Meloidogyne javanica

    by Virginia Ruiz‐Ferrer, Javier Cabrera, Isabel Martinez‐Argudo, Haydeé Artaza, Carmen Fenoll, Carolina Escobar

    SUMMARY: Root‐knot nematodes (RKNs, Meloidogyne spp.) are sedentary biotrophic pathogens that establish within the vascular cylinder of plant roots, forming a gall and inducing several feeding cells, giant cells (GCs), essential for completion of their life cycle. GCs suffer gene expression changes, repeated mitosis and endoreduplication events. Transcriptomics has revealed that an extensive down‐regulation of transcripts, a molecular signature of early‐developing galls and GCs that is conserved in tomato and Arabidopsis, may be achieved through small RNA (sRNA) gene silencing pathways. The role of some microRNAs (miRNAs) in plant–RKN interactions has recently been addressed, but little is known about the regulatory roles of other sRNA types. Here, we perform a differential accumulation analysis to show which repeat‐associated small interfering RNAs (rasiRNAs) are distinctive or enriched in early Arabidopsis galls vs. uninfected roots. Those distinctive from galls are preferentially located in pericentromeric regions with predominant sizes of 24 and 22 nucleotides. Gall‐distinctive rasiRNAs target primarily GYPSY and COPIA retrotransposons, which show a marked repression in galls vs. uninfected roots. Infection tests and phenotypic studies of galls from Meloidogyne javanica in Arabidopsis mutants impaired in post‐transcriptional gene silencing and/or canonical RNA‐directed DNA methylation (RdDM) pathways, as well as quantitative polymerase chain reaction analysis, suggest the implication of canonical and non‐canonical RdDM pathways during gall formation, possibly through the regulation of retrotransposons. This process may be crucial for the maintenance of genome integrity during the reprogramming process of galls/GCs from their vascular precursor cells, and/or to ensure a faithful DNA replication during the repeated mitosis/endoreduplication that concurs with feeding site formation.


  • Open Access

    5-gene differential expression predicts stability of human intestinal allografts

    by Paloma Talayero, Lola Alonso-Guirado, Guillermo Padilla, Haydee Artaza, Ana Dopazo, Fátima Sánchez-Cabo, Sarbelio Rodríguez-Muñoz, Jorge Calvo-Pulido, Esther Mancebo, Mario García de Lacoba, et al.


  • Open Access

    PIsCO: A Performance indicators framework for collection of bioinformatics resource metrics

    by Haydee Artaza, John M. Hancock, Rafael C. Jimenez, Manuel Corpas

    We present PIsCO, a server-side JavaScript framework for the collection, registration and sharing of metrics that can be used to evaluate the impact of bioinformatics-related resources such as software, repositories, training or databases. The metrics framework can be used to capture standard definitions of metrics, facilitate the collection of data, monitor resources and share data to be reused by other teams, laboratories or academic institutions. In addition, PIsCO is able to collect those metrics and present them in a visual way to allow their easy interpretation.

  • Open Access

    PIsCO: A Performance indicators framework for collection of bioinformatics resource metrics

    by Haydee Artaza, John M. Hancock, Rafael C. Jimenez, Manuel Corpas

    We present PIsCO, a server-side JavaScript framework for the collection, registration and sharing of metrics that can be used to evaluate the impact of bioinformatics-related resources such as software, repositories, training or databases. The metrics framework can be used to capture standard definitions of metrics, facilitate the collection of data, monitor resources and share data to be reused by other teams, laboratories or academic institutions. In addition, PIsCO is able to collect those metrics and present them in a visual way to allow their easy interpretation.

  • Open Access

    Top 10 metrics for life science software good practices

    by Haydee Artaza, Neil Chue Hong, Manuel Corpas, Angel Corpuz, Rob W.W. Hooft, Rafael C. Jiménez, Brane Leskošek, Brett G. Olivier, Jan Stourac, Radka Svobodová Vařeková, et al.

    Metrics for assessing adoption of good development practices are a useful way to ensure that software is sustainable, reusable and functional. Sustainability means that the software used today will be available - and continue to be improved and supported - in the future. We report here an initial set of metrics that measure good practices in software development. This initiative differs from previously developed efforts in being a community-driven grassroots approach where experts from different organisations propose good software practices that have reasonable potential to be adopted by the communities they represent. We not only focus our efforts on understanding and prioritising good practices, we assess their feasibility for implementation and publish them here.